• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肛门癌生存情况:一项社会经济学分析。

Anal cancer survival: a socioeconomic analysis.

机构信息

James Cook University Hospital, Middlesbrough, UK.

Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

出版信息

Ann R Coll Surg Engl. 2021 Mar;103(3):191-196. doi: 10.1308/rcsann.2020.7019.

DOI:10.1308/rcsann.2020.7019
PMID:33645271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9158002/
Abstract

INTRODUCTION

Squamous cell carcinoma is the most common variant of anal malignancy. Certain disease-related factors have been established in determining survival. These include tumour size, differentiation and nodal involvement. Other factors such as HIV status, human papillomavirus infection, smoking and socioeconomic disparity may have important roles, however few data are available on the UK population. We aim to correlate social deprivation and survival of anal cancer patients at a tertiary centre.

MATERIALS AND METHODS

All consecutive cases diagnosed with anal squamous cell carcinoma and treated as per local protocol between July 2010 and April 2017 were included. The pathological and demographical details were collected from a prospectively maintained database. Socioeconomic deprivation was defined for each postcode using the Index of Multiple Deprivation decile compiled by local governments in England. Survival was estimated using Kaplan-Meier analysis and Cox regression was used to investigate the effect of different factors on overall survival.

RESULTS

A total of 129 patients with anal squamous cell carcinoma over a median follow-up of 43 months were included. Overall survival for the entire patient cohort was 87.7% (95% confidence interval, CI, 82.0-93.7%), 75.5% (95% CI 67.5-84.5%) and 68.9% (95% CI 59.7-79.6%) at one year, three years and five years, respectively. On multivariate analysis, Index of Multiple Deprivation and income do not significantly influence overall survival ( = 0.79, hazard ratio, HR, 1.07; 95% CI 0.61-1.63), ( = 0.99, HR=1.00; 95% CI 0.61-1.63), respectively. Increased risk of death was observed for male sex ( = 0.02, HR=2.80; 95% CI 1.02-5.50) and larger tumour size ( = 0.01, HR=1.64; 95% CI 1.12-2.41).

CONCLUSION

In contrast to US studies, there is little difference in survival between the least deprived and most deprived groups. We attribute this to equal access to intensity-modulated radiation therapy-based chemoradiotherapy. Thus, a highly effective treatment made available to all mitigates any survival difference between socioeconomic groups.

摘要

引言

鳞状细胞癌是肛门恶性肿瘤最常见的变异型。某些与疾病相关的因素已被确定可影响生存。这些因素包括肿瘤大小、分化程度和淋巴结受累情况。其他因素,如 HIV 状态、人乳头瘤病毒感染、吸烟和社会经济差异,可能具有重要作用,但英国人群的数据很少。我们旨在分析三级中心肛门癌患者的社会贫困程度与生存情况的相关性。

材料和方法

纳入 2010 年 7 月至 2017 年 4 月期间,根据当地方案治疗的所有连续诊断为肛门鳞状细胞癌的病例。从前瞻性维护的数据库中收集了病理和人口统计学详细信息。每个邮政编码的社会经济贫困程度都使用英格兰地方政府编制的多因素剥夺指数进行定义。使用 Kaplan-Meier 分析估计生存情况,并使用 Cox 回归分析调查不同因素对总生存的影响。

结果

共纳入 129 例肛门鳞状细胞癌患者,中位随访时间为 43 个月。整个患者队列的总体生存率为 87.7%(95%置信区间,82.0-93.7%)、75.5%(95%置信区间 67.5-84.5%)和 68.9%(95%置信区间 59.7-79.6%),分别为 1 年、3 年和 5 年。多变量分析显示,多因素剥夺指数和收入对总体生存率没有显著影响(=0.79,风险比,HR,1.07;95%置信区间 0.61-1.63),(=0.99,HR=1.00;95%置信区间 0.61-1.63)。男性(=0.02,HR=2.80;95%置信区间 1.02-5.50)和较大的肿瘤大小(=0.01,HR=1.64;95%置信区间 1.12-2.41)与死亡风险增加相关。

结论

与美国的研究相比,在最贫困和最富裕人群之间,生存情况差异不大。我们认为这是由于能够平等获得基于调强放疗的放化疗。因此,一种对所有人都有效的高度有效的治疗方法,减轻了社会经济群体之间的任何生存差异。

相似文献

1
Anal cancer survival: a socioeconomic analysis.肛门癌生存情况:一项社会经济学分析。
Ann R Coll Surg Engl. 2021 Mar;103(3):191-196. doi: 10.1308/rcsann.2020.7019.
2
Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.肛管腺癌、肛门鳞状细胞癌和直肠腺癌患者的生存情况比较
Clin Colorectal Cancer. 2016 Mar;15(1):47-53. doi: 10.1016/j.clcc.2015.07.007. Epub 2015 Aug 1.
3
Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.鳞状细胞肛管癌的放化疗:预后因素综述
Colorectal Dis. 2016 Nov;18(11):1080-1086. doi: 10.1111/codi.13342.
4
Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.保险状况和教育水平可预测肛门鳞状细胞癌治疗接受情况和生存率的差异。
Cancer Epidemiol. 2020 Aug;67:101723. doi: 10.1016/j.canep.2020.101723. Epub 2020 May 11.
5
Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.血清 CYFRA 21-1 在接受放(化)疗的肛管鳞癌患者中的预后价值。
BMC Cancer. 2018 Apr 13;18(1):417. doi: 10.1186/s12885-018-4335-4.
6
Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.原发肛门鳞癌与肛门腺癌的治疗模式和结局比较。
Dis Colon Rectum. 2019 Dec;62(12):1448-1457. doi: 10.1097/DCR.0000000000001506.
7
Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.接受调强放射治疗的肛管癌患者的毒性反应和生存率
Ann R Coll Surg Engl. 2019 Mar;101(3):168-175. doi: 10.1308/rcsann.2018.0202. Epub 2018 Nov 28.
8
Rational treatment options for T1/2N0M0 squamous cell carcinoma of the anal canal: a population-based study combined with external validation.肛管鳞癌 T1/2N0M0 患者的合理治疗选择:一项基于人群的研究并结合外部验证。
Oncologist. 2024 Aug 5;29(8):e1003-e1011. doi: 10.1093/oncolo/oyae068.
9
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.根治性放化疗后采用调强放疗同步加量治疗肛门鳞状细胞癌的复发模式和预测因素。
Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):329-339. doi: 10.1016/j.ijrobp.2019.10.016. Epub 2019 Oct 17.
10
Factors Influencing Outcomes and Survival in Anal Cancer.影响肛门癌结局和生存的因素。
Curr Oncol. 2024 Sep 2;31(9):5151-5163. doi: 10.3390/curroncol31090381.

引用本文的文献

1
Very Late-Onset Serious Chronic Adverse Effects After Radical Chemoradiotherapy for Anal Canal Cancer.肛管癌根治性放化疗后极晚期严重慢性不良反应
J Clin Med. 2025 May 29;14(11):3841. doi: 10.3390/jcm14113841.
2
Factors Influencing Outcomes and Survival in Anal Cancer.影响肛门癌结局和生存的因素。
Curr Oncol. 2024 Sep 2;31(9):5151-5163. doi: 10.3390/curroncol31090381.

本文引用的文献

1
Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.尽管有医疗保险和医疗补助保险,但社会经济地位对乳腺癌生存的差异。
Milbank Q. 2018 Dec;96(4):706-754. doi: 10.1111/1468-0009.12355.
2
Impact of socioeconomic status on survival for patients with anal cancer.社会经济地位对肛门癌患者生存的影响。
Cancer. 2018 Apr 15;124(8):1791-1797. doi: 10.1002/cncr.31186. Epub 2018 Mar 12.
3
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529.根据放射治疗肿瘤学组(RTOG)0529号研究,一大群接受剂量调强适形放疗(IMRT)的肛管癌患者的长期结局和毒性反应
Adv Radiat Oncol. 2017 Feb 6;2(2):110-117. doi: 10.1016/j.adro.2017.01.009. eCollection 2017 Apr-Jun.
5
Pathology of Anal Cancer.肛管癌病理学
Surg Oncol Clin N Am. 2017 Jan;26(1):57-71. doi: 10.1016/j.soc.2016.07.013.
6
Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.人类免疫缺陷病毒/艾滋病、人乳头瘤病毒与肛门癌。
Surg Oncol Clin N Am. 2017 Jan;26(1):17-31. doi: 10.1016/j.soc.2016.07.010.
7
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.肛门癌:ESMO-ESSO-ESTRO 临床实践指南:诊断、治疗和随访。
Radiother Oncol. 2014 Jun;111(3):330-9. doi: 10.1016/j.radonc.2014.04.013. Epub 2014 Jun 16.
8
Socio-economic disadvantage and demographics as factors in stage of colorectal cancer presentation and survival.社会经济劣势和人口统计学因素在结直肠癌发病阶段及生存中的作用
ANZ J Surg. 2015 Mar;85(3):135-9. doi: 10.1111/ans.12709. Epub 2014 Jun 6.
9
Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).肛门癌复发和生存的预后因素:来自英国癌症研究协调委员会首次肛门癌试验(ACT I)成熟结果的假设生成。
Cancer. 2013 Feb 15;119(4):748-55. doi: 10.1002/cncr.27825. Epub 2012 Sep 25.
10
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006.如果消除英格兰癌症生存率中的社会经济不平等现象,将会避免多少死亡?一项基于全国人口的研究,1996-2006 年。
Eur J Cancer. 2012 Jan;48(2):270-8. doi: 10.1016/j.ejca.2011.10.008. Epub 2011 Nov 15.